NCT02915523 2024-01-10Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerSyndax PharmaceuticalsPhase 1/2 Completed140 enrolled 25 charts
NCT03029585 2021-04-27Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian CancerNanOlogy, LLCPhase 2 Terminated10 enrolled 13 charts
NCT03146663 2021-02-21NUC-1031 in Patients With Platinum-Resistant Ovarian CancerNuCana plcPhase 2 Terminated53 enrolled 19 charts